FABRY DISEASE - OVEREXPRESSION AND CHARACTERIZATION OF HUMAN ALPHA-GALACTOSIDASE A FOR RECOMBINANT ENZYME THERAPY

被引：0
|
作者：
IOANNOU, YA [1 ]
BISHOP, DF [1 ]
DESNICK, RJ [1 ]
机构：
[1] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
来源：
CLINICAL RESEARCH | 1991年 / 39卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A325 / A325
页数：1
相关论文
共 50 条
  • [1] Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease
    Germain, Dominique P.
    Linhart, Ales
    [J]. FRONTIERS IN GENETICS, 2024, 15
  • [2] Structural basis of Fabry disease and corrective effect of yeast recombinant human alpha-galactosidase on Fabry mice
    Sakuraba, H.
    Matsuzawa, F.
    Aikawa, S.
    Kotani, M.
    Kawashima, I
    Ohsawa, M.
    Tajima, Y.
    Chiba, Y.
    Jigami, Y.
    Kanzaki, T.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 22 - 22
  • [3] Recombinant enzyme therapy for Fabry disease:: Absence of editing of human α-galactosidase A mRNA
    Blom, D
    Speijer, D
    Linthorst, GE
    Donker-Koopman, WG
    Strijland, A
    Aerts, JMFG
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (01) : 23 - 31
  • [4] FABRY DISEASE - ISOLATION OF A CDNA CLONE ENCODING HUMAN ALPHA-GALACTOSIDASE A
    CALHOUN, DH
    BISHOP, DF
    BERNSTEIN, HS
    QUINN, M
    HANTZOPOULOS, P
    DESNICK, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) : 7364 - 7368
  • [5] FABRY DISEASE - DIAGNOSIS BY ALPHA-GALACTOSIDASE ACTIVITIES IN TEARS
    JOHNSON, DL
    DELMONTE, MA
    COTLIER, E
    DESNICK, RJ
    [J]. CLINICA CHIMICA ACTA, 1975, 63 (01) : 81 - 90
  • [6] Enzyme replacement therapy with recombinant alpha-galactosidase A in Fabry disease: Preliminary experience in patients with end-stage renal disease or post transplant.
    Germain, DP
    Bonfils, P
    Boutouyrie, P
    Brion, N
    Froissart, M
    Jacquot, C
    Jeunemaitre, X
    Orssaud, C
    Plouin, PF
    Richalet, B
    Toussaint, JF
    Fiessinger, JN
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 673 - 673
  • [7] alpha-Galactosidase A deficient mice: A model of Fabry disease
    Ohshima, T
    Murray, GJ
    Swaim, WD
    Longenecker, G
    Quirk, JM
    Cardarelli, CO
    Sugimoto, Y
    Pastan, I
    Gottesman, MM
    Brady, RO
    Kulkarni, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2540 - 2544
  • [8] Molecular damage in Fabry disease: Characterization and prediction of alpha-galactosidase A pathological mutations
    Riera, Casandra
    Lois, Sergio
    Dominguez, Carmen
    Fernandez-Cadenas, Israel
    Montaner, Joan
    Rodriguez-Sureda, Victor
    de la Cruz, Xavier
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2015, 83 (01) : 91 - 104
  • [9] Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment
    van der Veen, S. J.
    van Kuilenburg, A. B. P.
    Hollak, C. E. M.
    Kaijen, P. H. P.
    Voorberg, J.
    Langeveld, M.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : 162 - 168
  • [10] Alpha-Galactosidase — Genzyme GeneralFabrazyme®, Agalsidase Beta, Recombinant Human α-Galactosidase A
    [J]. Drugs in R & D, 2003, 4 (2) : 115 - 118
12345